Comparación of maternal and perinatal outcomes in the conservative management of preterm premature rupture of membranes between the use of erythromycin and clindamycin;Comparación de resultados maternos y perinatales en el tratamiento conservador de la rotura prematura de membranas pretérmino entre el uso de eritromicina y clindamicina

Ginecologia y Obstetricia de Mexico

Volumn 79, Issue 7, 2011, Pages 403-410

  Ballinas, Ariadna Hernández ^a   Farfán, José Ángel López ^b   Guevara, Catalina Gámez ^c  

^a BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^b Jefe de la División de Ginecología y Obstetricia   (Puerto Rico)

^c Hospital General Regional   (Puerto Rico)

Author keywords

Clindamycin; Erythromycin; Prematurity; Preterm premature rupture of membranes

Indexed keywords

CLINDAMYCIN; ERYTHROMYCIN;

ARTICLE; CERVICAL INFECTION; CHORIOAMNIONITIS; COMPARATIVE STUDY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DECIDUOENDOMETRITIS; ENDOMETRITIS; FEMALE; FEMALE GENITAL TRACT INFECTION; HUMAN; INTERMETHOD COMPARISON; NECROTIZING ENTEROCOLITIS; OUTCOME ASSESSMENT; PERINATAL OUTCOME; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; RISK FACTOR; SEPSIS; URINARY TRACT INFECTION;

ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHORIOAMNIONITIS; CLINDAMYCIN; ENDOMETRITIS; ENTEROCOLITIS, NECROTIZING; ERYTHROMYCIN; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RESPIRATORY DISTRESS SYNDROME, NEWBORN; RISK FACTORS; SEPSIS; URINARY TRACT INFECTIONS; UTERINE CERVICITIS; YOUNG ADULT;

EID: 79960307724     PISSN: 03009041     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol 2003;101(1):178-193.
2. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007;109(4):1007-1019.
3. Royal College of Obstetricians and Gynaecologists (RCOG). Preterm prelabour rupture of membranes. London (UK): Royal College of Obstetricians and Gynaecologists (RCOG); 2006;11 (Guideline; no. 44).
4. Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part I. Obstet Gynecol Surv 2004;59(9):669-677.
5. Canavan TP, Simhan HN, Caritis S. An evidence-based approach to the evaluation and treatment of premature rupture of membranes: Part II. Obstet Gynecol Surv 2004;59(9):678-689.
6. Tran SH, Cheng YW, Kaimal AJ, Caughey AB. Length of rupture of membranes in the setting of premature rupture of membranes at term and infectious maternal morbidity. Am J Obstet Gynecol 2008;198(6):700.e1-5.
7. Pristauz G, Bauer M, Maurer-Fellbaum U, Rotky-Fast C, et al. Neonatal outcome and two-year follow-up after expectant management of second trimester rupture of membranes. Int J Gynaecol Obstet 2008;101(3):264-268.
8. Gopalani S, Krohn M, Meyn L, Hitti J, Crombleholme WR. Contemporary management of preterm premature rupture of membranes: determinants of latency and neonatal outcome. Am J Perinatol 2004;21(4):183-190.
9. Kenyon S, Boulvain M, Neilson J. Antibiotics for preterm rupture of the membranes: a systematic review. Obstet Gynecol 2004;104(5 Pt 1):1051-1057.
10. Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001;357(9261):979-988.